Cue Biopharma CUE
NASDAQ CUE
$19.26 +2.22 (+13.03%)
As of: Oct 21, 2026 · 2:57 PM EDT

Cue Biopharma (CUE) Interest Expenses (2022)

Updated

Cue Biopharma (CUE) reported Interest Expenses of $124,000 for Q3 2022, down 39.8% from the prior quarter.

Analysis

Cue Biopharma (CUE) Interest Expenses (2022) Analysis & Trends

Over the twelve months ended Sep 30, 2022, Cue Biopharma's Interest Expenses came in at $355,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,137.36 Bn 1,105.95 Bn 19.71 Bn -
2 Johnson & Johnson 617.62 Bn 536.15 Bn 17.26 Bn 281.00 Mn
3 AbbVie 501.17 Bn 474.28 Bn 12.70 Bn -
4 Merck 368.13 Bn 322.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 261.23 Bn 234.92 Bn 12.86 Bn 435.00 Mn
7 Amgen 236.68 Bn 192.08 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 190.97 Bn 165.17 Bn 6.22 Bn 247.00 Mn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn -
10 Cue Biopharma 122.19 Mn 31.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 124,000.00
Jun 30, 2022 206,000.00
Mar 31, 2022 25,000.00
API Access

Cue Biopharma Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=CUE&period=max&api_key=YOUR_API_KEY